Baxter (NYSE: BAX) reported Q4 EPS of $0.44, $0.10 worse than the analyst estimate of $0.54. Revenue for the quarter came in at $2.97 billion versus the consensus estimate of $2.84 billion.

GUIDANCE:

Baxter sees FY2026 EPS of $1.85-$2.05, versus the consensus of $2.25.

For earnings history and earnings-related data on Baxter (BAX) click here.